Mobile

Azacitidine compared to conventional chemotherapy in consolidation of elderly patients (> 65 years) with acute leukemia after the first complete response

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-000981-40

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Investigate whether consolidation treatment with repeated courses of azacitidine prolongs leukemia–free survival (LFS) as compared to standard consolidation chemotherapy in elderly (≥65y) patients with AML in CR1.

Liens